Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet

Shares of Bright Minds Biosciences Inc. (DRUG) have gained 2.9% over the past four weeks to close the last trading session at $60.47, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $82.4 indicates a potential upside of 36.3%.The average comprises five short-term price targets ranging from a low of $72.00 to a high of $93.00, with a standard deviation of $7.64. While the lowest ...